XML 78 R11.htm IDEA: XBRL DOCUMENT
v3.2.0.727

Balance Sheets-Additional Information | 12 Months Ended
--- | ---
Jun. 30, 2015
Balance Sheets Additional Information [Abstract] |
Balance Sheets-Additional Information | 4. Balance Sheets—Additional Information ​
As of June 30 | ​ | ​ | 2015 | ​ | ​ | 2014 | ​
Accounts receivable, net | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Trade accounts receivable | ​ | ​ | ​ | $ | 114,477 | ​ | ​ | ​ | ​ | $ | 115,093 | ​ | ​
Allowance for doubtful accounts | ​ | ​ | ​ | ​ | (3,378) |  | ​ | ​ | ​ | ​ | (1,235) | ​ | ​
​ | ​ | ​ | ​ | $ | 111,099 | ​ | ​ | ​ | ​ | $ | 113,858 | ​ | ​
​
As of June 30 | ​ | ​ | 2015 | ​ | ​ | 2014 | ​
Allowance for doubtful accounts | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Balance at beginning of period | ​ | ​ | ​ | $ | 1,235 | ​ | ​ | ​ | ​ | $ | 658 | ​ | ​
Provision for bad debts | ​ | ​ | ​ | ​ | 2,587 | ​ | ​ | ​ | ​ | ​ | 226 | ​ | ​
Effect of changes in exchange rates | ​ | ​ | ​ | ​ | (218) | ​ | ​ | ​ | ​ | ​ | 351 | ​ | ​
Bad debt write-offs (recovery) | ​ | ​ | ​ | ​ | (226) | ​ | ​ | ​ | ​ | ​ | — | ​ | ​
Balance at end of period | ​ | ​ | ​ | $ | 3,378 | ​ | ​ | ​ | ​ | $ | 1,235 | ​ | ​
​
For the year ended June 30, 2013, the beginning balance for allowance for doubtful accounts was $1,041, the provision for bad debts was ($124), the bad debt write-offs was $6 and the effect of changes in exchange rates was ($265), resulting in an ending balance for allowance for doubtful accounts of  $658.
As of June 30 | ​ | ​ | 2015 | ​ | ​ | 2014 | ​
Inventories, net | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Raw materials | ​ | ​ | ​ | $ | 40,012 | ​ | ​ | ​ | ​ | $ | 44,306 | ​ | ​
Work-in-process | ​ | ​ | ​ | ​ | 7,617 | ​ | ​ | ​ | ​ | ​ | 7,518 | ​ | ​
Finished goods | ​ | ​ | ​ | ​ | 102,157 | ​ | ​ | ​ | ​ | ​ | 91,360 | ​ | ​
​ | ​ | ​ | ​ | $ | 149,786 | ​ | ​ | ​ | ​ | $ | 143,184 | ​ | ​
Property, plant and equipment, net | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Land | ​ | ​ | ​ | $ | 9,130 | ​ | ​ | ​ | ​ | $ | 9,773 | ​ | ​
Buildings and improvements | ​ | ​ | ​ | ​ | 50,276 | ​ | ​ | ​ | ​ | ​ | 51,364 | ​ | ​
Machinery and equipment | ​ | ​ | ​ | ​ | 171,797 | ​ | ​ | ​ | ​ | ​ | 172,530 | ​ | ​
​ | ​ | ​ | ​ | ​ | 231,203 | ​ | ​ | ​ | ​ | ​ | 233,667 | ​ | ​
Accumulated depreciation | ​ | ​ | ​ | ​ | (126,789) | ​ | ​ | ​ | ​ | ​ | (124,508) | ​ | ​
​ | ​ | ​ | ​ | $ | 104,414 | ​ | ​ | ​ | ​ | $ | 109,159 | ​ | ​
​
Certain facilities in Israel are on land leased for a nominal amount from the Israel Land Authority. The lease expires in July 2062. Certain facilities in Israel are on leased land. The lease expires in November 2035. Net equipment under capital leases was $48 and $142 at June 30, 2015 and 2014, respectively, including accumulated depreciation of  $42 and $79, respectively. Property, plant and equipment, net includes internal-use software costs, net of accumulated depreciation, of  $6,747 and $9,019 at June 30, 2015 and 2014, respectively. Machinery and equipment includes construction-in-progress of  $5,748 and $4,782 at June 30, 2015 and 2014, respectively.
As of June 30 | ​ | ​ | Weighted- Average Useful Life (Years) | ​ | ​ | 2015 | ​ | ​ | 2014 | ​
Intangibles, net | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Cost | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Medicated feed additive product registrations | ​ | ​ | ​ | ​ | 10 | ​ | ​ | ​ | ​ | $ | 11,753 | ​ | ​ | ​ | ​ | $ | 11,792 | ​ | ​
Rights to sell in international markets | ​ | ​ | ​ | ​ | 10 | ​ | ​ | ​ | ​ | ​ | 4,292 | ​ | ​ | ​ | ​ | ​ | 4,292 | ​ | ​
Customer relationships | ​ | ​ | ​ | ​ | 13 | ​ | ​ | ​ | ​ | ​ | 10,615 | ​ | ​ | ​ | ​ | ​ | 10,702 | ​ | ​
Technology | ​ | ​ | ​ | ​ | 12 | ​ | ​ | ​ | ​ | ​ | 38,580 | ​ | ​ | ​ | ​ | ​ | 28,259 | ​ | ​
Distribution agreements | ​ | ​ | ​ | ​ | 4 | ​ | ​ | ​ | ​ | ​ | 3,298 | ​ | ​ | ​ | ​ | ​ | 3,447 | ​ | ​
Trade names, trademarks and other | ​ | ​ | ​ | ​ | 5 | ​ | ​ | ​ | ​ | ​ | 2,740 | ​ | ​ | ​ | ​ | ​ | 2,740 | ​ | ​
In-process research and development | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 1,579 | ​ | ​ | ​ | ​ | ​ | — | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 72,857 | ​ | ​ | ​ | ​ | ​ | 61,232 | ​ | ​
​
As of June 30 | ​ | ​ | Weighted- Average Useful Life (Years) | ​ | ​ | 2015 | ​ | ​ | 2014 | ​
Accumulated amortization | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Medicated feed additive product registrations | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (10,669) | ​ | ​ | ​ | ​ | ​ | (11,039) | ​ | ​
Rights to sell in international markets | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (4,292 | )​ | ​ | ​ | ​ | ​ | (4,292) | ​ | ​
Customer relationships | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (5,267) | ​ | ​ | ​ | ​ | ​ | (4,265) | ​ | ​
Technology | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (9,741) | ​ | ​ | ​ | ​ | ​ | (6,510) | ​ | ​
Distribution agreements | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (3,298) | ​ | ​ | ​ | ​ | ​ | (3,309) | ​ | ​
Trade names, trademarks and other | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (2,309) | ​ | ​ | ​ | ​ | ​ | (2,014) | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (35,576) | ​ | ​ | ​ | ​ | ​ | (31,429) | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | $ | 37,281 | ​ | ​ | ​ | ​ | $ | 29,803 | ​ | ​
​
As of June 30 | ​ | ​ | 2015 | ​ | ​ | 2014 | ​
Other assets | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Goodwill | ​ | ​ | ​ | $ | 12,613 | ​ | ​ | ​ | ​ | $ | 12,613 | ​ | ​
Acquisition related note receivable | ​ | ​ | ​ | ​ | 5,000 | ​ | ​ | ​ | ​ | ​ | — | ​ | ​
Equity method investments | ​ | ​ | ​ | ​ | 4,725 | ​ | ​ | ​ | ​ | ​ | 5,619 | ​ | ​
Insurance investments | ​ | ​ | ​ | ​ | 4,788 | ​ | ​ | ​ | ​ | ​ | 4,626 | ​ | ​
Deferred financing fees | ​ | ​ | ​ | ​ | 4,335 | ​ | ​ | ​ | ​ | ​ | 5,199 | ​ | ​
Deferred income taxes | ​ | ​ | ​ | ​ | 221 | ​ | ​ | ​ | ​ | ​ | 3,486 | ​ | ​
Other | ​ | ​ | ​ | ​ | 6,213 | ​ | ​ | ​ | ​ | ​ | 2,529 | ​ | ​
​ | ​ | ​ | ​ | $ | 37,895 | ​ | ​ | ​ | ​ | $ | 34,072 | ​ | ​
​
Goodwill balances did not change during 2015 and 2014. We evaluate our investments in equity method investees for impairment if circumstances indicate that the fair value of the investment may be impaired. The assets underlying a $4,364 equity investment are currently idled; we have concluded the investment is not currently impaired, based on expected future operating cash flows and/or disposal value.
As of June 30 | ​ | ​ | 2015 | ​ | ​ | 2014 | ​
Accrued expenses and other current liabilities | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Employee related accruals | ​ | ​ | ​ | $ | 22,273 | ​ | ​ | ​ | ​ | $ | 20,813 | ​ | ​
Commissions and rebates | ​ | ​ | ​ | ​ | 4,148 | ​ | ​ | ​ | ​ | ​ | 2,973 | ​ | ​
Insurance related | ​ | ​ | ​ | ​ | 1,368 | ​ | ​ | ​ | ​ | ​ | 1,395 | ​ | ​
Professional fees | ​ | ​ | ​ | ​ | 3,543 | ​ | ​ | ​ | ​ | ​ | 4,229 | ​ | ​
Deferred consideration on acquisitions | ​ | ​ | ​ | ​ | 1,196 | ​ | ​ | ​ | ​ | ​ | 1,420 | ​ | ​
Product liability claims | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | 5,286 | ​ | ​
Other accrued liabilities | ​ | ​ | ​ | ​ | 12,935 | ​ | ​ | ​ | ​ | ​ | 13,745 | ​ | ​
​ | ​ | ​ | ​ | $ | 45,463 | ​ | ​ | ​ | ​ | $ | 49,861 | ​ | ​
Other liabilities | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Pension and other retirement benefits | ​ | ​ | ​ | $ | 30,909 | ​ | ​ | ​ | ​ | $ | 31,025 | ​ | ​
Long term and deferred income taxes | ​ | ​ | ​ | ​ | 19,098 | ​ | ​ | ​ | ​ | ​ | 14,282 | ​ | ​
Deferred consideration on acquisitions | ​ | ​ | ​ | ​ | 7,266 | ​ | ​ | ​ | ​ | ​ | 2,879 | ​ | ​
Other long term liabilities | ​ | ​ | ​ | ​ | 8,375 | ​ | ​ | ​ | ​ | ​ | 10,128 | ​ | ​
​ | ​ | ​ | ​ | $ | 65,648 | ​ | ​ | ​ | ​ | $ | 58,314 | ​ | ​
​
As of June 30 | ​ | ​ | 2015 | ​ | ​ | 2014 | ​
Accumulated other comprehensive income (loss) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Derivative instruments | ​ | ​ | ​ | $ | (1,542) | ​ | ​ | ​ | ​ | $ | 386 | ​ | ​
Foreign currency translation adjustment | ​ | ​ | ​ | ​ | (32,723) | ​ | ​ | ​ | ​ | ​ | (1,409) | ​ | ​
Unrecognized net pension gains (losses) | ​ | ​ | ​ | ​ | (19,884) | ​ | ​ | ​ | ​ | ​ | (16,663) | ​ | ​
Income tax (provision) benefit on derivative instruments | ​ | ​ | ​ | ​ | 63 | ​ | ​ | ​ | ​ | ​ | 63 | ​ | ​
Income tax (provision) benefit on long-term intercompany investments | ​ | ​ | ​ | ​ | 4,923 | ​ | ​ | ​ | ​ | ​ | — | ​ | ​
Income tax (provision) benefit on pension gains (losses) | ​ | ​ | ​ | ​ | (2,437) | ​ | ​ | ​ | ​ | ​ | (2,437) | ​ | ​
​ | ​ | ​ | ​ | $ ​ | (51,600) | ​ | ​ | ​ | ​ | $ | (20,060) | ​ | ​
​

X
- References No definition available. + Details
Name: | pahc_BalanceSheetsAdditionalInformationAbstract
Namespace Prefix: | pahc_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References No definition available. + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration